Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Pretreatment for WMT in IBS
NCT06437041Not yet recruiting
- Start
- Jun 2024
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Ornidazole + WMT with Placebo + WMT (2 arms). Primary endpoints: Gastrointestinal Symptoms Rating Scales at 8 weeks and IBS Symptom Severity Scale at 8 weeks. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
ornidazole
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT06437041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06437041.